Mohmood B Aldapt, Nancy Kassem, Randa Al-Okka, Rula Ghasoub, Dina Soliman, Mohammad A Abdulla, Deena Mudawi, Feryal Ibrahim, Mohamed A Yassin
Journal: Acta bio-medica : Atenei Parmensis 2019;89(3-S):33-37
PMID: 29633731
We present a rather uncommon side effect observed in a 20-year-old man with acute promyelocytic leukemia during treatment with ATRA. He developed a high platelet counts reaching up to 1655×10⁹/L on day 29 of ATRA treatment, and started to recover spontaneously on day 33 of treatment, without any change in ATRA, or adding any cytoreduction therapy. No complications associated with thrombocytosis were observed. IL-6 seems to play an important role in the pathogenesis of the thrombocytosis induced by ATRA. However, it is unclear what are the precipitating factors for this rare phenomenon and whether it is caused by certain predisposing factors that might be related to patient's, disease pathogenesis or other unknown factors.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.